Fera, along with its manufacturer, Steri-Med Pharma, are pleased to provide Erythromycin Ophthalmic Ointment, alleviating a critical product drug shortage. Read the Dear Healthcare Provider Letter that provides information about the product, the drug shortage and how to order.

Note: Fera and Steri-Med are coordinating with the U.S. FDA Drug Shortage Staff to increase Erythromycin Ophthalmic Ointment availability by temporary importation of non-FDA approved product from Canada.